Sep-2021 T2T In Mild-to-Moderate UC: Can We Achieve Long-Term Disease Modification?
Speakers: Prof. Alisa Hart (UK), Dr. Nik Raihan (Malaysia), Prof. Shu-Chen Wei (Taiwan), Prof. John Ding (Australia)
This talk begins with Prof Hart’s keynote speech on evolving therapeutic goals in UC, especially in the out-patient setting, and how she chooses the best option for her patients by adopting a holistic approach. Then Dr. Raihan further elaborated the role of histological assessment for treatment response as histological activity is more predictive of clinical relapse and corticosteroid use compared to endoscopic findings alone. A series of illustrative clinical cases are presented to show how T2T strategies are deployed in the real-world setting.
IBD Undone: New Update in T2T Strategies in UC (by Prof. Alison Hart) 2’ – 28’
Targeting Histological Healing in UC: From the Pathologist Perspective (by Dr. Nik Raihan) 29’ – 46’
Case Presentations on UC & Panel Discussion (by Prof. Shu-Chen Wei and Prof. John Ding) 47’ – 90’
